Abstract: The present invention relates to the prognosis of the outcome of a cancer in a patient, which prognosis is based on the quantification of one or several biological markers that are indicative of the presence of, or alternatively the level of, the adaptive immune response of said patient against said cancer.
Type:
Grant
Filed:
December 14, 2018
Date of Patent:
April 12, 2022
Assignees:
ISERM (Institut National de la Santé et de la Recherche Médicale), Université Paris Descartes, Assistance Publique-Hôpitaux de Paris (APHP)
Abstract: The present invention relates to methods for the in vitro screening of an anti-metastatic compound that inhibits activity, methods for determining in vitro the presence or absence of a metastatic cancer in a subject by quantifying SK3 activity, methods for the in vitro assessment of the progression of the metastatic property of a cancer by quantifying SK3.
Type:
Application
Filed:
August 3, 2007
Publication date:
December 17, 2009
Applicant:
ISERM(Institut National de la Sante et de la Recherche Medicale
Inventors:
Marie Potier, Christophe Vandier, Virginie Joulin
Abstract: A therapeutic endo-rectal probe comprises a piezoelectric transducer element mounted in a support member itself connected to a rigid guide means enabling endo-rectal insertion of the probe, the outside shape of the support member preferably being that of a disk having an outline that is for the most part substantially circular or substantially elliptical, thereby facilitating endo-rectal insertion.
Type:
Grant
Filed:
February 22, 1994
Date of Patent:
December 12, 1995
Assignees:
Technomed Medical Systems, Iserm-Institut National de la Sante et de la Recherche Medicale
Inventors:
Jean Y. Chapelon, Dominique Cathignol, Albert Gelet, Emmanuel Blanc